SUBMIT VIA EMAIL OR ONLINE FORM?
Using the consumer input form on the website allows you to nominate only one treatment at a time. If you’d like to comment on both gepants you can email your comments to the PBAC email listed below using the questions in the guide below for your response.
It is important to note that each gepant has a different indication: Atogepant is for the prevention of migraine while Rimegepant is indicated for the treatment of an acute migraine attack in their PBS application. We do not recommend duplicating your submission for each treatment.
Many people may find it easier to make their comments about both options and emailing their submission to: commentsPBAC@health.gov.au
WHAT SHOULD I SAY ON MY SUBMISSION?
Below are the form questions and response suggestions.
Click here to begin the form >>
Medicine Name: ATOGEPANT or RIMEGEPANT (select from the drop-down menu).
Submitted by: Individual (select from the drop-down menu).
Email: Your email
Phone number: Your phone
Street address: Your address
Suburb: Your suburb
State: Your state
Postcode: Your postcode
Declaration of interest:
Please include any declarations you wish to make regarding your PBAC submission. If you have no declarations to make, please respond “nil”.
Please indicate whether you are a person with this medical condition, a friend or family member, a prescriber, a representative of an organisation or other interested person.
What comments would you like the PBAC to take into account when it considers this submission?
This is where you post your personal experience.
- How does migraine limit your activities, your work, or other responsibilities or commitments?
- What would it mean to you to find an effective treatment that works as an acute and preventive treatment for migraine?
- How important is the benefit that gepants do not cause medication overuse headache like many other acute migraine and pain medications. How does the removal of this risk reduce anxiety, fear and stress about the impact of the medications you are taking for migraine.
- The advantage gepants may have over triptans when it comes to cardiovascular risk factors or when you are not able to take triptans because of cardiovascular concerns.
- How satisfied are you with your current treatment?
- What symptoms or side effects can’t be controlled with your current treatment?
- If you haven’t used the new medicine yet, what would you like most from it?
- If you currently have access to the treatment, what will happen to you, your family and/or work if it does not get covered by the PBS?
Note that this is not a “test” and all submissions will be reviewed by the committee and are appreciated for their personal and private nature. Be honest, direct, polite and respectful.
How did you learn about this submission process?
Migraine & Headache Australia monitored the submission process and notified the community about this comment period.
READY TO SUBMIT?
Submit using the form on the government website or email your response to CommentsPBAC@health.gov.au